Navigation Links
inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
Date:2/28/2008

: The Company significantly strengthened its senior

management team in 2007 with the promotion of R. Blane Walter to

President, Terrell G. Herring to Chief Operating Officer and other key

leadership appointments. In addition, in late 2007 inVentiv initiated

several key new investments, primarily in technology in its Clinical

segment and in integrated account management, in order to further drive

longer-term growth and margin expansion.

-- Strong Cash Flow: As a result of the strength of inVentiv's

operations, the Company generated $58.7 million of cash flow from

operations during 2007, including $43.2 million in the fourth quarter,

and finished the year with $98.1 million of cash and marketable

securities on the balance sheet as of December 31, 2007.

Mr. Eran Broshy, Chairman and Chief Executive Officer of inVentiv Health, commented, "I am very pleased with inVentiv's record fourth quarter and full year results, demonstrating our unique leadership position built on a strong and diversified business model. We have continued to effectively execute for our clients by offering best-in-class offerings, and also are increasingly delivering broader integrated solutions to our clients. At the same time, I am excited at our increasing new win momentum and the significant new business pipeline we are pursuing, which now stands at over $400 million."

2008 Guidance Reconfirmed

Based on the Company's strong performance during the fourth quarter and full year of 2007, the Company is, at this time, reconfirming its 2008 revenue guidance of $1.05 - $1.15 billion and adjusted earnings per share guidance of $1.80 - $1.90 including stock compensation expense (GAAP earnings per share guidance of $1.78 - $1.88).

Adjusted guidance figures exclude derivative interest income or expense related to the Company's interest rate hedge on its term loan facility, certain
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
2. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
3. inVentiv Health Provides Updated Information on December 11th Investor Day
4. inVentiv Health Creates Client Development and Integration Team
5. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
6. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
7. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
8. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
9. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
10. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
11. UCLA launches network to study health care disparities affecting minorities
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 2Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 3Health News:Hurricane Devastation Touches the Nation's Blood Supply 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 2Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 4Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 5Health News:New High Performance Brushless dc Motors From NMB 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 3
Breaking Medicine Technology:HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Genetic changes shown to be important indicators for disease progression in cervical cancer patients 61278 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 33SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 43SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 53SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 63SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 73SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 83SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 93SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 103SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 113SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 123SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 133SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 143SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 153SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 163SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 173SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 183SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 193SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 203SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 21Vivakor Presents at Nutraceutical Event 61275 1Vivakor Presents at Nutraceutical Event 61275 2Vivakor Presents at Nutraceutical Event 61275 3Vivakor Presents at Nutraceutical Event 61275 4Vivakor Presents at Nutraceutical Event 61275 5Vivakor Presents at Nutraceutical Event 61275 6